Roderick Wong, M.D.
Activist
First SEC filing: April 29, 2026 · Latest: April 29, 2026
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 18, 2026 | RCKT | A | 78,960 | · | · | 78,960 Direct | · | Acquired | (price as of 2026-10-05) |
| June 18, 2026 | RCKT | A | 27,832 | · | · | 75,499 Direct | +58.39% | Acquired | (price as of 2026-10-05) |
| June 18, 2025 | RCKT | A | 17,667 | · | · | 47,667 Direct | +58.89% | Acquired | (price as of 2026-10-05) |
| June 18, 2025 | RCKT | A | 30,000 | · | · | 30,000 Direct | · | Acquired | (price as of 2026-10-05) |
| June 13, 2024 | RCKT | A | 3,325 | $15.04 | $50,008 | 3,325 Direct | · | Acquired | -82.6% (price as of 2026-10-05) |
| June 13, 2024 | RCKT | A | 23,944 | · | · | 23,944 Direct | · | Acquired | (price as of 2026-10-05) |
| June 22, 2023 | RCKT | A | 3,590 | $13.93 | $50,009 | 3,590 Direct | · | Acquired | -81.3% (price as of 2026-10-05) |
| June 22, 2023 | RCKT | A | 25,850 | · | · | 25,850 Direct | · | Acquired | (price as of 2026-10-05) |
| Jan. 24, 2023 | OBIO | P | 1,808,512 | $10.00 | $18,085,120 | 2,808,512 Indirect | +180.85% | Acquired | -39.7% (price as of 2026-10-05) |
| July 22, 2022 | OBIO | P | 1,000,000 | $10.01 | $10,010,000 | 1,000,000 Indirect | · | Acquired | -39.8% (price as of 2026-10-05) |
| June 13, 2022 | RCKT | A | 5,876 | $6.80 | $39,957 | 5,876 Direct | · | Acquired | -61.6% (price as of 2026-10-05) |
| June 13, 2022 | RCKT | A | 47,745 | · | · | 47,745 Direct | · | Acquired | (price as of 2026-10-05) |
| June 16, 2021 | RNA | A | 15,000 | · | · | 15,000 Direct | · | Acquired | |
| June 14, 2021 | RCKT | A | 15,295 | · | · | 15,295 Direct | · | Acquired | (price as of 2026-10-05) |
| June 16, 2020 | RCKT | A | 27,000 | · | · | 27,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Dec. 11, 2019 | IMVT | P | 31,500 | $10.92 | $343,980 | 902,498 Indirect | +3.62% | Acquired | 204.5% (price as of 2026-10-05) |
| Dec. 10, 2019 | IMVT | P | 25,971 | $10.38 | $269,579 | 870,998 Indirect | +3.07% | Acquired | 220.3% (price as of 2026-10-05) |
| Dec. 6, 2019 | IMVT | P | 50,000 | $10.20 | $510,000 | 845,027 Indirect | +6.29% | Acquired | 226.0% (price as of 2026-10-05) |
| Dec. 6, 2019 | IMVT | P | 400,000 | $10.25 | $4,100,000 | 795,027 Indirect | +101.26% | Acquired | 224.4% (price as of 2026-10-05) |
| Dec. 5, 2019 | IMVT | P | 20,000 | $10.15 | $203,000 | 395,027 Indirect | +5.33% | Acquired | 227.6% (price as of 2026-10-05) |
| Dec. 4, 2019 | IMVT | P | 20,000 | $10.15 | $203,000 | 375,027 Indirect | +5.63% | Acquired | 227.6% (price as of 2026-10-05) |
| Dec. 3, 2019 | IMVT | P | 20,000 | $10.21 | $204,200 | 355,027 Indirect | +5.97% | Acquired | 225.7% (price as of 2026-10-05) |
| Dec. 2, 2019 | IMVT | P | 20,000 | $10.40 | $208,000 | 335,027 Indirect | +6.35% | Acquired | 219.7% (price as of 2026-10-05) |
| Nov. 29, 2019 | IMVT | P | 26,918 | $10.45 | $281,293 | 315,027 Indirect | +9.34% | Acquired | 218.2% (price as of 2026-10-05) |
| Nov. 27, 2019 | IMVT | P | 4,000 | $10.48 | $41,920 | 288,109 Indirect | +1.41% | Acquired | 217.3% (price as of 2026-10-05) |
| Nov. 26, 2019 | IMVT | P | 4,000 | $10.49 | $41,960 | 284,109 Indirect | +1.43% | Acquired | 217.0% (price as of 2026-10-05) |
| Nov. 25, 2019 | IMVT | P | 4,000 | $10.50 | $42,000 | 280,109 Indirect | +1.45% | Acquired | 216.7% (price as of 2026-10-05) |
| Nov. 22, 2019 | IMVT | P | 2,000 | $10.54 | $21,080 | 276,109 Indirect | +0.73% | Acquired | 215.5% (price as of 2026-10-05) |
| Nov. 21, 2019 | IMVT | P | 15,194 | $10.42 | $158,321 | 274,109 Indirect | +5.87% | Acquired | 219.1% (price as of 2026-10-05) |
| Nov. 20, 2019 | IMVT | P | 29,805 | $10.39 | $309,674 | 258,915 Indirect | +13.01% | Acquired | 220.0% (price as of 2026-10-05) |
| Nov. 19, 2019 | IMVT | P | 29,805 | $10.25 | $305,501 | 229,110 Indirect | +14.95% | Acquired | 224.4% (price as of 2026-10-05) |
| Nov. 18, 2019 | IMVT | P | 29,805 | $10.25 | $305,501 | 199,305 Indirect | +17.58% | Acquired | 224.4% (price as of 2026-10-05) |
| Nov. 15, 2019 | IMVT | P | 13,000 | $10.29 | $133,770 | 169,500 Indirect | +8.31% | Acquired | 223.1% (price as of 2026-10-05) |
| Nov. 14, 2019 | IMVT | P | 13,000 | $10.17 | $132,210 | 156,500 Indirect | +9.06% | Acquired | 226.9% (price as of 2026-10-05) |
| Nov. 13, 2019 | IMVT | P | 13,000 | $10.17 | $132,210 | 143,500 Indirect | +9.96% | Acquired | 226.9% (price as of 2026-10-05) |
| Nov. 12, 2019 | IMVT | P | 100,000 | $10.17 | $1,017,000 | 130,500 Indirect | +327.87% | Acquired | 226.9% (price as of 2026-10-05) |
| Nov. 11, 2019 | IMVT | P | 13,000 | $10.18 | $132,340 | 30,500 Indirect | +74.29% | Acquired | 226.6% (price as of 2026-10-05) |
| Nov. 7, 2019 | IMVT | P | 17,500 | $10.18 | $178,150 | 17,500 Indirect | · | Acquired | 226.6% (price as of 2026-10-05) |
| Jan. 28, 2019 | RCKT | A | 40,500 | · | · | 40,500 Direct | · | Acquired | (price as of 2026-10-05) |
| March 29, 2018 | RCKT | A | 47,000 | · | · | 47,000 Direct | · | Acquired | (price as of 2026-10-05) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 18, 2026 | RCKT | Stock Option (Right to Buy) | Common Stock | $3.35 | June 18, 2036 | 78,960 | Acquired |
| June 13, 2024 | RCKT | Stock Option (Right to Buy) | Common Stock | $22.86 | June 13, 2034 | 3,325 | Acquired |
| June 13, 2024 | RCKT | Stock Option (Right to Buy) | Common Stock | $22.86 | June 13, 2034 | 23,944 | Acquired |
| June 22, 2023 | RCKT | Stock Option (Right to Buy) | Common Stock | $21.56 | June 22, 2033 | 3,590 | Acquired |
| June 22, 2023 | RCKT | Stock Option (Right to Buy) | Common Stock | $21.56 | June 22, 2033 | 25,850 | Acquired |
| June 13, 2022 | RCKT | Stock Option (Right to Buy) | Common Stock | $10.77 | June 13, 2032 | 5,876 | Acquired |
| June 13, 2022 | RCKT | Stock Option (Right to Buy) | Common Stock | $10.77 | June 13, 2032 | 47,745 | Acquired |
| June 16, 2021 | RNA | Stock Option (Right to Buy) | Common Stock | $26.09 | June 15, 2031 | 15,000 | Acquired |
| June 14, 2021 | RCKT | Stock Option (Right to Buy) | Common Stock | $47.25 | June 14, 2031 | 15,295 | Acquired |
| June 16, 2020 | RCKT | Stock Option (Right to Buy) | Common Stock | $19.90 | June 16, 2030 | 27,000 | Acquired |
| Jan. 28, 2019 | RCKT | Stock Option (Right to Buy) | Common Stock | $14.56 | Jan. 28, 2029 | 40,500 | Acquired |
| March 29, 2018 | RCKT | Stock Option (Right to Buy) | Common Stock | $18.75 | March 29, 2028 | 47,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).